Clinical Trials

In 2007, CircuLite initiated a European CE Mark trial for the Synergy circulatory support system. This trial is ongoing and evaluating the safety and patient quality of life improvements associated with device support of greater than six months. To review data from this trial or relevant publications, please click here.

CircuLite is also planning to initiate an IDE trial in the U.S. with Synergy to support eventual FDA approval of the system. Additionally, CircuLite is advancing an endovascular system, which is approaching clinical evaluation in Europe. If you are interested in learning more about or in participating in CircuLite’s planned clinical trials, please click here.